History of GenoMethods

The history of GenoMethods follows the rise of computational biology from early machine-learning resources to today’s AI-enabled biotechnology newsroom.

2002

GenoMethods appeared as a resource for artificial intelligence and machine learning methods in bioinformatics, connected to a special issue on methods in functional genomics. The editorial record named Paola Sebastiani, Marco Ramoni and Isaac Kohane as guest editors and placed the project at the junction of statistics, machine learning and biomedical informatics.

The core subject was functional genomics: microarrays, gene-expression dynamics, clustering, classification, Bayesian modelling, genetic markers and the challenge of making computational biology useful to working laboratories.

2003 to 2006

The site’s practical identity grew through method pages and software references. CAGED addressed temporal gene-expression clustering, BEST supported haplotype-tagging SNP selection, BADGE introduced Bayesian differential-expression analysis and SCA supported Bayesian network reasoning in genomics.

These resources were not decorative content. They were cited by researchers because they solved concrete analytical problems at a time when biology was becoming data-rich faster than most laboratories could adapt.

2007 to 2011

References to GenoMethods continued through biomedical papers, software manuals and bioinformatics link directories. CAGED and BEST appeared in studies across gene expression, genetic association and disease research, showing that the site’s methods reached beyond a single lab or announcement.

The site’s value during this period came from usefulness. Researchers needed working programs, clear documentation and a common vocabulary for methods that were still new to many biomedical readers.

2012 to 2022

GenoMethods remained visible in scholarly citations and indexed traces while the web around bioinformatics changed. Large databases, cloud workflows, genome browsers, single-cell platforms and open-source pipelines became central infrastructure for the field.

The indexed presence of navigation such as about, news, archive and home showed the project’s continued editorial shape. The publication’s next role became clear: preserve the methods-first identity while expanding into public coverage of biotechnology.

2026

GenoMethods returned as a global publisher covering biotechnology, bioinformatics and AI in biology. The renewed site treats the old archive as a foundation for a larger newsroom focused on companies, products, trials, methods, data and human impact.

The modern editorial scope includes AlphaFold-era structural biology, AI drug discovery, CRISPR therapies, multiomics, diagnostics, spatial biology, cell therapy, synthetic biology and healthspan research. The through-line remains constant: methods first, evidence always, public clarity without loss of precision.